Researchers suspect compounds in citrus may sensitize skin to sunlight, but further study is needed.
Study reveals a 35% increase in all-cause mortality risk compared with non-use.
Treatment with this compound resulted in higher circulating levels of 25(OH)D compared with ergocalciferol in Hispanic CKD patients.
60% of products contained less active ingredient than their labels said, while 23% had more.
Preoperative weight loss greater than 10% and operative time more than 6 hours also increased the risk.
Researchers found similar post-surgical outcomes between bladder cancer patients having primary and salvage radical cystectomy.
A prolonged hospital stay and discharge to a nursing facility were among the risks.
Donor and recipient outcomes are similar to those associated with laparoscopic removal of left donor kidneys.
In a study, the treatment was associated with a 53% decreased risk of death from kidney cancer compared with expectant management.
Ten years after the laser procedure, no reoperation was needed for 95% of patients treated for symptomatic benign prostatic hyperplasia.
Researchers observe no association between prostate cancer and urethritis, orchitis, or epididymitis.
Radiation treatment is associated with an increased risk of requiring minimally invasive urologic procedures.
In a phase 2 trial, enzalutamide treatment was associated with significantly longer progression-free survival.
Age-adjusted prostate cancer-specific comorbidity index strongly predictive of other-cause mortality.
Slightly higher odds for men on ED drugs, but lifestyle factors are the likelier culprit.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Dietary Interventions Improve Hyperphosphatemia Treatment
- Genomic Prostate Score Predicts PCa Recurrence, Adverse Pathology
- New Dyslipidemia Guidelines Eliminate Treatment Targets
- Complications More Likely After Radiotherapy vs. Surgery for PCa
- High-Risk Patients Screened for Bladder Cancer Rarely Die from It